
For allergy company ALK, the US is the promised land, and the company has been trying to establish itself there for several years.
Despite progress in 2021, it was still not CEO Carsten Hellmann’s year. The failure to crack the US market hits him where it hurts, as the payout of part of his bonus is tied to success on the market, Danish financial daily Børsen reports.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app